Tatsuhiko Azegami Selected Research

Glomerulopathy with fibronectin deposits

7/2022

Fibronectin Glomerulopathy Confused with Glomerular Endothelial Injury in a Patient with Takotsubo Cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuhiko Azegami Research Topics

Disease

8	Hypertension (High Blood Pressure) 01/2021 - 07/2010
4	Albuminuria 01/2019 - 01/2012
4	Communicable Diseases (Infectious Diseases) 01/2018 - 09/2014
3	Kidney Diseases (Kidney Disease) 01/2020 - 07/2010
3	Proteinuria 10/2015 - 05/2012
2	Chronic Renal Insufficiency 01/2022 - 01/2022
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2019
2	Hypertrophy 01/2021 - 07/2010
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 07/2022
1	Glomerulopathy with fibronectin deposits 07/2022
1	Takotsubo Cardiomyopathy 07/2022
1	Ureteral Obstruction 01/2022
1	Inflammation (Inflammations) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Pruritus (Itching) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Body Weight (Weight, Body) 06/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020
1	Pain (Aches) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Chronic Disease (Chronic Diseases) 01/2018
1	Pneumococcal Infections 01/2018
1	Essential Hypertension 09/2012
1	Atherosclerotic Plaque (Atheroma) 01/2012
1	Atherosclerosis 01/2012

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 01/2022 - 09/2011
4	ReninIBA 10/2015 - 01/2012
4	AngiotensinsIBA 10/2015 - 09/2011
3	nephrinIBA 01/2019 - 06/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2015 - 07/2010
3	Angiotensin IIIBA 10/2015 - 09/2012
3	Angiotensin Receptor AntagonistsIBA 10/2015 - 07/2010
2	CholesterolIBA 06/2021 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2019
2	Therapeutic UsesIBA 01/2019 - 01/2018
2	AntigensIBA 01/2019 - 01/2018
2	SaltsIBA 10/2014 - 01/2012
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2022
1	Attenuated VaccinesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Connective Tissue Growth FactorIBA 01/2022
1	Adenine FDA LinkGeneric 01/2022
1	Protein Subunit VaccinesIBA 01/2022
1	Chemokine CCL17IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 06/2021
1	LDL CholesterolIBA 06/2021
1	HDL CholesterolIBA 06/2021
1	Uric Acid (Urate)IBA 06/2021
1	Streptozocin (Streptozotocin)FDA Link 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2021
1	AlbuminsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Leptin ReceptorsIBA 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2020
1	CytosineIBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Type 1 Angiotensin ReceptorIBA 01/2018
1	pneumococcal surface protein AIBA 01/2018
1	Kruppel-Like Factor 4IBA 10/2015
1	Angiotensin IIBA 09/2012
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 05/2012
1	LipidsIBA 01/2012
1	BiglycanIBA 01/2012
1	candesartanIBA 01/2012
1	Proteoglycans (Proteoglycan)IBA 01/2012
1	Apolipoproteins E (ApoE)IBA 01/2012
1	ApolipoproteinsIBA 01/2012
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2011

Therapy/Procedure

2	Therapeutics 01/2022 - 09/2012
1	Peritoneal Dialysis 01/2022
1	Immunotherapy 01/2019
1	Mucosal Administration 01/2018
1	Aftercare (After-Treatment) 01/2012